Clinical Trial of Efficacy of Dashmoola Haritaki Avaleha in Tamaka Shwasa with special reference to Bronchial Asthma

Efficacy of Dashmoola Haritaki Avaleha in Tamaka Shwasa with special reference to Bronchial Asthma A Randomized Controlled Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065734

Enrollment

Registered

2024-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with Classical signs and symptoms of Tamaka Shwasa with special reference to bronchial asthma 2. Age group 20-70yrs 3. Either Gender 4. Mild and moderate grade of Bronchial Asthma as per GINA 5. Patient indicated for Koshta Shodhana 6. Patient willing to participate with Written Consent.

Exclusion criteria

Exclusion criteria: 1. The patients diagnosed with COPD ( Chronic bronchitis, Emphysema), Pneumonia, Cardiac asthma, Tuberculosis, Pleural effusion, Cardiac pathology. 2. Patients with Status Asthamaticus 3. Patients with Diabetes Mellitus and Hypertension, Uraemia, Acidosis, Malignancy . 4. Pregnant Woman, Lactating Woman

Design outcomes

Primary

Measure	Time frame
•To evaluate the efficacy of Dashmoola Haritaki Avaleha in Tamaka Shwasa with special reference to Bronchial Asthma. •To compare the effect of Dashmoola Haritaki Avaleha and Vasa Avaleha in Tamaka Shwasa with special reference to Bronchial Asthma. •To compare the effect of Dashmoola Haritaki Avaleha and Vasa Avaleha in Health related Quality of Life According to GINA Guidelines. Timepoint: Subjective parameters will be assessed on baseline on 0th day ,2nd week and 4th week and 45th day of the intervention.	—

Measure

Time frame

•To evaluate the efficacy of Dashmoola Haritaki Avaleha in Tamaka Shwasa with special reference to Bronchial Asthma. •To compare the effect of Dashmoola Haritaki Avaleha and Vasa Avaleha in Tamaka Shwasa with special reference to Bronchial Asthma. •To compare the effect of Dashmoola Haritaki Avaleha and Vasa Avaleha in Health related Quality of Life According to GINA Guidelines. Timepoint: Subjective parameters will be assessed on baseline on 0th day ,2nd week and 4th week and 45th day of the intervention.

—

Secondary

Measure	Time frame
CBC ESR AEC and SPIROMETERY test will be done on 0th day and 45th day of the intervention.Timepoint: Objective parameters will be assessed on baseline on 0th day ,2nd week and 4th week and 45th day of the intervention.	—

Countries

India

Contacts

Public ContactDr Suhas Kumar Shetty

KAHERS Shri B.M.Kankanwadi Ayurveda Mahavidyalaya college And Research centre

drsuhasshetty@gmail.com9449603234

Outcome results